What is the appropriate management for a 50-year-old male patient presenting with hypertension and chills?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypertension with Chills in a 50-Year-Old Male

This patient requires urgent evaluation for infection or other acute illness causing chills before addressing the blood pressure, as chills suggest an underlying acute process that may be driving the hypertensive response and could represent a medical emergency.

Immediate Assessment Priority

The presence of chills is a red flag that must be evaluated immediately, as this suggests:

  • Infectious process (sepsis, pneumonia, urinary tract infection, endocarditis) 1
  • Acute illness that may be causing secondary hypertension 2
  • Potential hypertensive emergency if end-organ damage is present 3, 1

Perform targeted evaluation for acute end-organ damage including assessment for severe headache, visual disturbances, chest pain, dyspnea, altered mental status, or focal neurological deficits 4. If any of these are present alongside BP ≥180/110 mmHg, this constitutes a hypertensive emergency requiring immediate intervention 1.

Blood Pressure Classification and Management

At 150/90 mmHg, this patient has Grade 1 hypertension (BP 140-159/90-99 mmHg) 3.

If No Acute End-Organ Damage Present:

Do NOT rapidly lower blood pressure in the emergency setting - this is asymptomatic hypertension that does not require acute BP reduction and may be harmful 3. The 2006 Annals of Emergency Medicine guidelines explicitly state that initiating treatment for asymptomatic hypertension in the ED is not necessary when patients have follow-up, and rapidly lowering BP in asymptomatic patients is unnecessary and may be harmful 3.

Outpatient Management Approach:

Initiate combination pharmacological therapy as recommended by the 2024 ESC guidelines, since confirmed hypertension (≥140/90 mmHg) warrants prompt treatment regardless of cardiovascular risk 3.

Preferred initial regimen:

  • RAS blocker (ACE inhibitor or ARB) + calcium channel blocker (CCB) as a fixed-dose single-pill combination 3
  • Alternative: RAS blocker + thiazide/thiazide-like diuretic 3

Target blood pressure: 120-129 mmHg systolic if well tolerated, with minimum target <140/90 mmHg 3. Achieve control within 3 months of treatment initiation 3.

Critical Workup for Chills

Obtain immediately:

  • Temperature, complete vital signs
  • Complete blood count with differential
  • Blood cultures if febrile
  • Urinalysis and urine culture
  • Chest X-ray
  • Basic metabolic panel, creatinine, eGFR 4
  • Consider additional infectious workup based on clinical presentation

Follow-Up Timeline

  • Reassess within 1 week given the BP elevation and acute symptoms 4
  • Check serum creatinine, eGFR, and potassium at 1-4 weeks after initiating RAS blocker therapy 4
  • Monthly visits until BP controlled 3

Lifestyle Modifications (Concurrent with Pharmacotherapy)

Implement immediately as these can reduce BP by 5-20 mmHg 4:

  • Sodium restriction to <2g/day 4
  • Moderate-intensity aerobic exercise ≥150 minutes/week 4
  • Weight loss if BMI >25 kg/m² 4
  • Limit alcohol to <100g/week 4
  • Mediterranean or DASH diet 4

Key Pitfall to Avoid

Do not treat the BP number in isolation - the chills indicate a potentially serious underlying condition that requires diagnosis and treatment. Approximately one-third of patients with diastolic BP >95 mmHg normalize before follow-up 3, and aggressive acute BP lowering without addressing the underlying cause could mask a serious infection or worsen outcomes.

References

Research

Therapeutic Approach to Hypertension Urgencies and Emergencies in the Emergency Room.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Severe Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the best initial treatment for a patient with severe hypertension (blood pressure 160/120 mmHg)?
What laboratory tests are recommended for a patient in hypertensive crisis?
How to manage an elderly patient with hypertension (high blood pressure) and dizziness?
What is the management plan for a patient with severely elevated blood pressure (hypertensive crisis) of 300/170mmHg, who presented at an ophthalmology camp?
What is the approach to a patient with a blood pressure of 160/110?
What is the reason to perform an echo with bubble study in a patient with a history of Transient Ischemic Attack (TIA)?
I have complex post-traumatic stress disorder (CPTSD), anxiety, secondary depression, and attention deficit disorder (ADD), and I'm currently taking Adderall (amphetamine and dextroamphetamine) and Rexulti (brexpiprazole). Since Rexulti and Concerta (methylphenidate) blunt the effect of my ADD medication, and I've had no success with selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), what alternative medications can I consider to manage my anxiety and depression without affecting my ADD treatment, and should I replace Rexulti with Buspar (buspirone)?
Should an elderly patient with cardiac disease and interstitial lung disease (ILD) receive vitamin D replacement therapy with a vitamin D level of 37 ng/mL?
Does iron deficiency impair cardiac function by causing decreased myocardial contractility in a patient with a history of cardiac issues, such as congenital heart disease?
What is the primary treatment for a patient with secondary adrenal insufficiency?
What is the appropriate treatment and management plan for a patient with gout arthritis who is intolerant to other urate-lowering therapies (ULT) and has impaired renal function, considering the use of Febuxostat (febuxostat)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.